In this week’s View, Dr. Eagle looks at a prospective multicenter cohort study that examined early and late aortic-related mortality and rupture after fenestrated-branched endovascular aortic repair of thoracoabdominal aortic aneurysms. He then explores periprocedural mortality in patients having PCI and a rise in biomarkers. Finally, Dr. Eagle discusses a systemic review and meta-analysis of lipoprotein(a) and calcific aortic valve stenosis progression. 

 Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at a study comparing three diuretic regimens in ambulatory congested heart failure (HF) patients (DEA-HF). He then explores a randomized trial that investigates the effects of implantable cardioverter-defibrillator (ICD) leads on the tricuspid valve and right ventricle. Finally, Dr. Eagle discusses the effects of rapid up-titration of neurohormonal blockade in patients with acute decompensated HF. 

Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at the ARISE-HF trial that examined racial differences in diabetic cardiomyopathy. He then explores established and emerging implications of treatment of genetic hypertrophic cardiomyopathy (HCM). Finally, Dr. Eagle discusses the use of GLP-1 agonists, including semaglutide vs. tirzepatide for weight loss in adults with overweight or obesity. 

 Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle discusses a state-of-the-art review on iron repletion for patients with heart failure and iron deficiency. He then explores the diagnosis and management of ventricular septal defect complicating acute myocardial infarction. Finally, Dr. Eagle discusses practical guidance for hemodynamic assessment by right heart catheterization in management of heart failure. 

Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at the clinical impact of early rhythm control and healthy lifestyles in patients with atrial fibrillation, then explores the use of low-dose aspirin in the prevention of atherosclerotic cardiovascular disease. Finally, Dr. Eagle discusses the association of autoimmune diseases with coronary atherosclerosis and ischemic events. 

Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at office measurement vs. ambulatory blood pressure monitoring and its associations with mortality in patients with or without diabetes. Dr. Eagle then reviews two related articles: a report in JACC on Artificial Intelligence and cardiovascular care, and a recent article from The Lancet on inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease in which AI played an important role. 

Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at secular trends of incidence and outcomes in severe aortic stenosis. He then examines titration of medications after acute heart failure. Finally, Dr. Eagle shares some thoughts on an analysis from the PARTNER2-S3 registry on the predictors and five-year clinical outcomes of pacemakers after TAVR. 

Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at excess apolipoprotein-B and cardiovascular risk, then examines a recent meta-analysis on treating pulmonary arterial hypertension. Finally, Dr. Eagle shares some thoughts on a SMART-C collaborative meta-analysis of sodium-glucose cotransporter-2 inhibitors and major adverse cardiovascular outcomes. 

Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting. He then examines a meta-analysis of invasive vs. conservative management of non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting. Finally, Dr. Eagle shares some thoughts on JACC’s recent State of the Art Review of arrhythmia-induced cardiomyopathy. 

Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at the diagnostic value of aortic valve calcification levels in the assessment of low-gradient aortic stenosis.  

 He then examines the prognostic value of microvascular resistance reserve after percutaneous coronary intervention in patients with myocardial infarction.  

 Finally, Dr. Eagle shares some thoughts on clinical outcomes associated with various microvascular injury patterns identified by cardiac MRI after STEMI. 

Subscribe to Eagle’s Eye View